General Information
    • ISSN: 2010-0221 (Print)
    • Abbreviated Title: Int. J. Chem. Eng. Appl.
    • Frequency: Biannually
    • DOI: 10.18178/IJCEA
    • Editor-in-Chief: Prof. Dr. Shen-Ming Chen
    • Executive Editor: Alice Loh
    • Abstracting/ Indexing:  CNKI, Google Scholar, EBSCO, ProQuest,  Crossref, etc.
    • Email: editor@ijcea.org
  • Jan 08, 2024 News! IJCEA switches to Biannually publication starting from 2024.
  • Jan 02, 2024 News! IJCEA will adopt Article-by-Article Work Flow staring from 2024.
Editor-in-chief
Prof. Dr. Shen-Ming Chen
National Taipei University of Technology, Taiwan
 

IJCEA 2025 Vol.16(2): 82-85
doi: 10.18178/ijcea.2025.16.2.844

Tyrosinase Inhibitory Properties of D-Qonamide™

Chanin Leksahakhun and Laichheang Yort*
Department of research and development, Beyond Laboratory (Thailand) Co., Ltd. Bangkok, Thailand
Email: chanin043.3@gmail.com (C.L.); y.laichheang@gmail.com (L.Y.)
*Corresponding author

Manuscript received April 22, 2025; accepted June 27, 2025; published August 8, 2025

Abstract—Tyrosinase is a key enzyme in melanin biosynthesis, catalyzing reactions that produce melanin in melanocytes and contributing to pigmentation in mammals and plants. This enzyme overactivity is a major contributing factor in hyperpigmentation disorders including as melasma, lentigo, and freckles. Current study has focused on combining active substances under the formulation D-Qonamide™: Dong Quai (Angelica sinensis) extract, grape (Vitis vinifera) skin extract (resveratrol), astragalus (Astragalus membranaceus) extract, and nicotinamide, to efficiently inhibit this enzyme, resulting in potential treatments for controlling various skin problems. The objective of this study is to evaluate the efficacy of these ingredients in addressing anti-tyrosinase activity. D-Qonamide™ were evaluated for their in vitro tyrosinase inhibitory effect. The enzymatic assay of D-Qonamide™ showed concentration-dependent tyrosinase inhibition, with activity reduced by 35.240±1.092% to 70.989±0.790% at concentrations of 2.00–10.00 mg/mL. Its IC50 was 4.948±0.126 mg/mL, indicating moderate inhibitory potency. In contrast, Kojic acid had a much lower IC50 of 0.674±0.002 mg/mL, making it approximately seven times more effective than D-Qonamide™. Together, these findings suggest that these ingredients, either individually or in combination, offer substantial potential for applications in nutraceuticals, cosmeceuticals, and functional health products targeting pigmentation and skin health.

Keywords—tyrosinase, antioxidant, polyphenol, melanin, Dong quai

[PDF]

Cite: Chanin Leksahakhun and Laichheang Yort, "Tyrosinase Inhibitory Properties of D-Qonamide™," International Journal of Chemical Engineering and Applications vol. 16, no. 2, pp. 844, 2025.

Copyright © 2010-2025. International Journal of Chemical Engineering and Applications. All rights reserved

Published by